These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 26825690)

  • 1. Characterization of a mutant form of human apolipoprotein B (Thr26_Tyr27del) associated with familial hypobetalipoproteinemia.
    Magnolo L; Noto D; Cefalù AB; Averna M; Calandra S; Yao Z; Tarugi P
    Biochim Biophys Acta; 2016 Apr; 1861(4):371-9. PubMed ID: 26825690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel nontruncating APOB gene mutation, R463W, causes familial hypobetalipoproteinemia.
    Burnett JR; Shan J; Miskie BA; Whitfield AJ; Yuan J; Tran K; McKnight CJ; Hegele RA; Yao Z
    J Biol Chem; 2003 Apr; 278(15):13442-52. PubMed ID: 12551903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic autophagy mediates endoplasmic reticulum stress-induced degradation of misfolded apolipoprotein B.
    Qiu W; Zhang J; Dekker MJ; Wang H; Huang J; Brumell JH; Adeli K
    Hepatology; 2011 May; 53(5):1515-25. PubMed ID: 21360721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missense mutations in APOB within the betaalpha1 domain of human APOB-100 result in impaired secretion of ApoB and ApoB-containing lipoproteins in familial hypobetalipoproteinemia.
    Burnett JR; Zhong S; Jiang ZG; Hooper AJ; Fisher EA; McLeod RS; Zhao Y; Barrett PH; Hegele RA; van Bockxmeer FM; Zhang H; Vance DE; McKnight CJ; Yao Z
    J Biol Chem; 2007 Aug; 282(33):24270-83. PubMed ID: 17588943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missense mutation Q384K in the APOB gene affecting the large lipid transfer module of apoB reduces the secretion of apoB-100 in the liver without reducing the secretion of apoB-48 in the intestine.
    Strøm TB; Asprusten E; Laerdahl JK; Øygard I; Hussain MM; Bogsrud MP; Leren TP
    J Clin Lipidol; 2023; 17(6):800-807. PubMed ID: 37718180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Janus-faced manifestations of homozygous familial hypobetalipoproteinemia due to apolipoprotein B truncations.
    Di Leo E; Eminoglu T; Magnolo L; Bolkent MG; Tümer L; Okur I; Tarugi P
    J Clin Lipidol; 2015; 9(3):400-5. PubMed ID: 26073401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular bases of low production rates of apolipoprotein B-100 and truncated apoB-82 in a mutant HepG2 cell line generated by targeted modification of the apolipoprotein B gene.
    Srivastava RA; Srivastava N; Averna M; Cefalu AB; Schonfeld G
    J Lipid Res; 1999 May; 40(5):901-12. PubMed ID: 10224159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B.
    Zhong S; Magnolo AL; Sundaram M; Zhou H; Yao EF; Di Leo E; Loria P; Wang S; Bamji-Mirza M; Wang L; McKnight CJ; Figeys D; Wang Y; Tarugi P; Yao Z
    J Biol Chem; 2010 Feb; 285(9):6453-64. PubMed ID: 20032471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AAA-ATPase p97 facilitates degradation of apolipoprotein B by the ubiquitin-proteasome pathway.
    Fisher EA; Lapierre LR; Junkins RD; McLeod RS
    J Lipid Res; 2008 Oct; 49(10):2149-60. PubMed ID: 18550891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hypobetalipoproteinemia in a hospital survey: genetics, metabolism and non-alcoholic fatty liver disease.
    Gutiérrez-Cirlos C; Ordóñez-Sánchez ML; Tusié-Luna MT; Patterson BW; Schonfeld G; Aguilar-Salinas CA
    Ann Hepatol; 2011; 10(2):155-64. PubMed ID: 21502677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous familial hypobetalipoproteinemia: A Turkish case carrying a missense mutation in apolipoprotein B.
    Yilmaz BS; Mungan NO; Di Leo E; Magnolo L; Artuso L; Bernardis I; Tumgor G; Kor D; Tarugi P
    Clin Chim Acta; 2016 Jan; 452():185-90. PubMed ID: 26612772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel APOB mutation in familial hypobetalipoproteinemia.
    Domenech M; Llano-Rivas I; Arroyo V; Ortega E
    J Clin Lipidol; 2022; 16(1):28-32. PubMed ID: 34852964
    [No Abstract]   [Full Text] [Related]  

  • 13. Homozygous familial hypobetalipoproteinemia: two novel mutations in the splicing sites of apolipoprotein B gene and review of the literature.
    Cefalù AB; Norata GD; Ghiglioni DG; Noto D; Uboldi P; Garlaschelli K; Baragetti A; Spina R; Valenti V; Pederiva C; Riva E; Terracciano L; Zoja A; Grigore L; Averna MR; Catapano AL
    Atherosclerosis; 2015 Mar; 239(1):209-17. PubMed ID: 25618028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hypobetalipoproteinemia caused by a mutation in the apolipoprotein B gene that results in a truncated species of apolipoprotein B (B-31). A unique mutation that helps to define the portion of the apolipoprotein B molecule required for the formation of buoyant, triglyceride-rich lipoproteins.
    Young SG; Hubl ST; Smith RS; Snyder SM; Terdiman JF
    J Clin Invest; 1990 Mar; 85(3):933-42. PubMed ID: 2312735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia.
    Cariou B; Ouguerram K; Zaïr Y; Guerois R; Langhi C; Kourimate S; Benoit I; Le May C; Gayet C; Belabbas K; Dufernez F; Chétiveaux M; Tarugi P; Krempf M; Benlian P; Costet P
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2191-7. PubMed ID: 19762784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the endoplasmic reticulum 60 protein ER-60 downregulates apoB100 secretion by inducing its intracellular degradation via a nonproteasomal pathway: evidence for an ER-60-mediated and pCMB-sensitive intracellular degradative pathway.
    Qiu W; Kohen-Avramoglu R; Rashid-Kolvear F; Au CS; Chong TM; Lewis GF; Trinh DK; Austin RC; Urade R; Adeli K
    Biochemistry; 2004 Apr; 43(16):4819-31. PubMed ID: 15096051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro functional characterization of splicing variants of the APOB gene found in familial hypobetalipoproteinemia.
    Rabacchi C; Simone ML; Pisciotta L; Di Leo E; Bocchi D; Pietrangelo A; D'Addato S; Bertolini S; Calandra S; Tarugi P
    J Clin Lipidol; 2019; 13(6):960-969. PubMed ID: 31629702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin-dependent and -independent proteasomal degradation of apoB associated with endoplasmic reticulum and Golgi apparatus, respectively, in HepG2 cells.
    Liao W; Chang BH; Mancini M; Chan L
    J Cell Biochem; 2003 Aug; 89(5):1019-29. PubMed ID: 12874835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic Differences Between Polygenic and Monogenic Hypobetalipoproteinemia.
    Rimbert A; Vanhoye X; Coulibaly D; Marrec M; Pichelin M; Charrière S; Peretti N; Valéro R; Wargny M; Carrié A; Lindenbaum P; Deleuze JF; Genin E; Redon R; Rollat-Farnier PA; Goxe D; Degraef G; Marmontel O; Divry E; Bigot-Corbel E; Moulin P; Cariou B; Di Filippo M
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e63-e71. PubMed ID: 33207932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypobetalipoproteinemias.
    Schonfeld G
    Annu Rev Nutr; 1995; 15():23-34. PubMed ID: 8527219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.